The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 3, Pages 329
Publisher
MDPI AG
Online
2019-03-08
DOI
10.3390/cancers11030329
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases
- (2018) Stephen P. Newman ADVANCED DRUG DELIVERY REVIEWS
- Perspectives on the past, present, and future of cancer nanomedicine
- (2018) Yu Seok Youn et al. ADVANCED DRUG DELIVERY REVIEWS
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non–Small-Cell Lung Cancer: Where Do We Stand?
- (2018) Meng Qiao et al. Clinical Lung Cancer
- Critical Parameters for Particle-Based Pulmonary Delivery of Chemotherapeutics
- (2018) Ali Dabbagh et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
- (2018) Hadeer M. Abdelaziz et al. JOURNAL OF CONTROLLED RELEASE
- New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation
- (2018) Rémi Rosière et al. MOLECULAR PHARMACEUTICS
- La chimiothérapie inhalée – partie 2 : clinique et applications potentielles
- (2018) R. Rosière et al. REVUE DES MALADIES RESPIRATOIRES
- La chimiothérapie inhalée – partie 1 : concept et challenges technologiques actuels
- (2018) R. Rosière et al. REVUE DES MALADIES RESPIRATOIRES
- Platinum pharmacokinetics in mice following inhalation of cisplatin dry powders with different release and lung retention properties
- (2017) Vincent Levet et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Development of controlled-release cisplatin dry powders for inhalation against lung cancers
- (2016) Vincent Levet et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy
- (2016) Rémi Rosière et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma
- (2016) Tian Luo et al. JOURNAL OF CONTROLLED RELEASE
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers
- (2016) Jeffry Weers et al. PHARMACEUTICAL RESEARCH
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
- (2015) Hiroshi Maeda ADVANCED DRUG DELIVERY REVIEWS
- Loco-regional administration of nanomedicines for the treatment of lung cancer
- (2015) Gabriela Garrastazu Pereira et al. DRUG DELIVERY
- Inhalable, large porous PLGA microparticles loaded with paclitaxel: preparation,in vitroandin vivocharacterization
- (2015) Shohreh Alipour et al. JOURNAL OF MICROENCAPSULATION
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Performing Dry Powder Inhalers of Paclitaxel DPPC/DPPG Lung Surfactant-Mimic Multifunctional Particles in Lung Cancer: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies
- (2014) Samantha A. Meenach et al. AAPS PHARMSCITECH
- Emerging inhalation aerosol devices and strategies: Where are we headed?
- (2014) Qi (Tony) Zhou et al. ADVANCED DRUG DELIVERY REVIEWS
- Phospholipids in pulmonary drug delivery
- (2014) Nathalie Wauthoz et al. EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Epidemiology of Lung Cancer
- (2013) Anthony J. Alberg et al. CHEST
- Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients
- (2013) Paul Zarogoulidis et al. Future Oncology
- Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology
- (2013) Kaid Darwiche et al. Future Oncology
- Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA
- (2013) Oleh Taratula et al. JOURNAL OF CONTROLLED RELEASE
- nab-Paclitaxel mechanisms of action and delivery
- (2013) Denise A. Yardley JOURNAL OF CONTROLLED RELEASE
- Pulmonary drug delivery: from generating aerosols to overcoming biological barriers—therapeutic possibilities and technological challenges
- (2013) Christian A Ruge et al. Lancet Respiratory Medicine
- Inhaled chemotherapy in lung cancer: future concept of nanomedicine
- (2012) Paul Zarogoulidis et al. International Journal of Nanomedicine
- Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung
- (2012) Alexander J. Chou et al. PEDIATRIC BLOOD & CANCER
- Paclitaxel loaded PEG5000–DSPE micelles as pulmonary delivery platform: Formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation
- (2011) Kanwaldeep K. Gill et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Feasibility and effectiveness of inhaled carboplatin in NSCLC patients
- (2011) Paul Zarogoulidis et al. INVESTIGATIONAL NEW DRUGS
- Formulations for Pulmonary Administration of Anticancer Agents to Treat Lung Malignancies
- (2011) Thiago C. Carvalho et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Aerosolized Gemcitabine in Patients with Carcinoma of the Lung: Feasibility and Safety Study
- (2011) Etienne Lemarie et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non-Small Cell Lung Cancer
- (2010) G. A. Otterson et al. CLINICAL CANCER RESEARCH
- Formulation strategy and use of excipients in pulmonary drug delivery
- (2010) Gabrielle Pilcer et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanomedicine
- (2010) Betty Y.S. Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Temozolomide-Based Dry Powder Formulations for Lung Tumor-Related Inhalation Treatment
- (2010) Nathalie Wauthoz et al. PHARMACEUTICAL RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started